secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001326190-25-000067
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune enters $200M ATM equity distribution agreement with Leerink Partners; terminates prior $150M ATM
--------------------------------------------------------------------------------

- Entered November 2025 Agreement with Leerink Partners for ATM offering of up to $200M common stock.
- Sales agent Leerink receives 3% commission on gross proceeds of shares sold under the program.
- Prior February 2025 ATM program (up to $150M) terminated effective November 6, 2025 without penalties.
- Shares sold through Nasdaq Global Market under Rule 415(a)(4) at the company's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619025000067/0001326190-25-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619025000067/alt-20251106x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-25-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer